BioMed Research International / 2009 / Article / Fig 2

Research Article

OXavidin for Tissue Targeting Biotinylated Therapeutics

Figure 2

Tissue residence of avidin, PEGavidin, and oxidized avidin. 125I-labeled avidin, PEGavidin, and oxidized avidin were formulated in 100 mM sodium acetate pH 5.5 and injected in the limb muscle at the dose of 50  g in 15  L/mouse. Mice were sacrificed 24 hours after injection and tissue samples weighted and counted in a gamma-counter. Data are expressed as % ID/100 mg of tissue. Each point is the average of 5 mice. Bars represent standard deviation. Student’s test was used for statistical analysis. NS: Not significant.

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.